Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03107988 |
|---|---|
| Brief Title: | NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922) |
| First Submitted : | March 21, 2017 |
| First Submitted that Met QC Criteria : | April 4, 2017 |
| First Posted : | April 11, 2017 |
| Last Update Submitted that Met QC Criteria : | February 7, 2024 |
| Last Update Posted : | February 9, 2024 |